Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from v3.6.5 to v3.6.6, indicating a new site release version. This change affects only metadata display and does not modify the study record content or history entries.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision stamp in the page footer has been updated to v3.6.5, indicating a newer build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check49 days agoChange DetectedThe footer now displays Revision: v3.6.4, replacing v3.6.3, indicating a new release of the site interface.SummaryDifference0.0%

- Check70 days agoChange DetectedStudy Record History now shows a new release entry: Revision: v3.6.3, and the preceding Revision: v3.6.2 entry has been removed. This updates the revision log to reflect the latest platform update.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a new software release has been deployed for the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe history now shows recruitment is closed, with the note that no longer looking for participants. The version in the history updates to Revision: v3.6.0, replacing the prior Revision: v3.5.5.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.